In the BioHarmony Drug Report Database
Moroctocog alfa
ReFacto AF (moroctocog alfa) is a protein pharmaceutical. Moroctocog alfa was first approved as ReFacto AF on 1999-04-13. It has been approved in Europe to treat hemophilia a.
Trade Name
|
ReFacto AF |
|---|---|
Common Name
|
moroctocog alfa |
ChEMBL ID
|
CHEMBL2109137 |
Indication
|
hemophilia a |
Drug Class
|
Image (chem structure or protein)
